Sendai virus for cancer immunotherapy

Yasuji Ueda, Mamoru Hasegawa, Yoshikazu Yonemitsu

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Citations (Scopus)

Abstract

Dendritic cells (DCs) have a crucial role to play in fighting nonself organisms and cells, including tumors. Clinically, numerous DC vaccinations have been attempted for cancer immunotherapy since the first trial, published in 1995, but with limited success. We found that Sendai virus (SeV) vector infection induces maturation of DCs and produces more powerful antitumor immunity against DCs in mouse models. We used a SeV vector as an immune booster for tumors and believe that this novel therapy, designated as immunostimulatory virotherapy, will offer potent treatment for tumors.

Original languageEnglish
Title of host publicationViral Applications of Green Fluorescent Protein
Subtitle of host publicationMethods and Protocols
PublisherHumana Press Inc.
Pages299-308
Number of pages10
ISBN (Print)9781934115879
DOIs
Publication statusPublished - Jan 1 2009
Externally publishedYes

Publication series

NameMethods in Molecular Biology
Volume515
ISSN (Print)1064-3745

Fingerprint

Sendai virus
Immunotherapy
Dendritic Cells
Neoplasms
Virus Diseases
Immunity
Vaccination
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics

Cite this

Ueda, Y., Hasegawa, M., & Yonemitsu, Y. (2009). Sendai virus for cancer immunotherapy. In Viral Applications of Green Fluorescent Protein: Methods and Protocols (pp. 299-308). (Methods in Molecular Biology; Vol. 515). Humana Press Inc.. https://doi.org/10.1007/978-1-59745-559-6_21

Sendai virus for cancer immunotherapy. / Ueda, Yasuji; Hasegawa, Mamoru; Yonemitsu, Yoshikazu.

Viral Applications of Green Fluorescent Protein: Methods and Protocols. Humana Press Inc., 2009. p. 299-308 (Methods in Molecular Biology; Vol. 515).

Research output: Chapter in Book/Report/Conference proceedingChapter

Ueda, Y, Hasegawa, M & Yonemitsu, Y 2009, Sendai virus for cancer immunotherapy. in Viral Applications of Green Fluorescent Protein: Methods and Protocols. Methods in Molecular Biology, vol. 515, Humana Press Inc., pp. 299-308. https://doi.org/10.1007/978-1-59745-559-6_21
Ueda Y, Hasegawa M, Yonemitsu Y. Sendai virus for cancer immunotherapy. In Viral Applications of Green Fluorescent Protein: Methods and Protocols. Humana Press Inc. 2009. p. 299-308. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-59745-559-6_21
Ueda, Yasuji ; Hasegawa, Mamoru ; Yonemitsu, Yoshikazu. / Sendai virus for cancer immunotherapy. Viral Applications of Green Fluorescent Protein: Methods and Protocols. Humana Press Inc., 2009. pp. 299-308 (Methods in Molecular Biology).
@inbook{255b391453ed4844b58f198d628cc7cd,
title = "Sendai virus for cancer immunotherapy",
abstract = "Dendritic cells (DCs) have a crucial role to play in fighting nonself organisms and cells, including tumors. Clinically, numerous DC vaccinations have been attempted for cancer immunotherapy since the first trial, published in 1995, but with limited success. We found that Sendai virus (SeV) vector infection induces maturation of DCs and produces more powerful antitumor immunity against DCs in mouse models. We used a SeV vector as an immune booster for tumors and believe that this novel therapy, designated as immunostimulatory virotherapy, will offer potent treatment for tumors.",
author = "Yasuji Ueda and Mamoru Hasegawa and Yoshikazu Yonemitsu",
year = "2009",
month = "1",
day = "1",
doi = "10.1007/978-1-59745-559-6_21",
language = "English",
isbn = "9781934115879",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "299--308",
booktitle = "Viral Applications of Green Fluorescent Protein",

}

TY - CHAP

T1 - Sendai virus for cancer immunotherapy

AU - Ueda, Yasuji

AU - Hasegawa, Mamoru

AU - Yonemitsu, Yoshikazu

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Dendritic cells (DCs) have a crucial role to play in fighting nonself organisms and cells, including tumors. Clinically, numerous DC vaccinations have been attempted for cancer immunotherapy since the first trial, published in 1995, but with limited success. We found that Sendai virus (SeV) vector infection induces maturation of DCs and produces more powerful antitumor immunity against DCs in mouse models. We used a SeV vector as an immune booster for tumors and believe that this novel therapy, designated as immunostimulatory virotherapy, will offer potent treatment for tumors.

AB - Dendritic cells (DCs) have a crucial role to play in fighting nonself organisms and cells, including tumors. Clinically, numerous DC vaccinations have been attempted for cancer immunotherapy since the first trial, published in 1995, but with limited success. We found that Sendai virus (SeV) vector infection induces maturation of DCs and produces more powerful antitumor immunity against DCs in mouse models. We used a SeV vector as an immune booster for tumors and believe that this novel therapy, designated as immunostimulatory virotherapy, will offer potent treatment for tumors.

UR - http://www.scopus.com/inward/record.url?scp=65649117375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65649117375&partnerID=8YFLogxK

U2 - 10.1007/978-1-59745-559-6_21

DO - 10.1007/978-1-59745-559-6_21

M3 - Chapter

SN - 9781934115879

T3 - Methods in Molecular Biology

SP - 299

EP - 308

BT - Viral Applications of Green Fluorescent Protein

PB - Humana Press Inc.

ER -